Cardiovascular Pipeline Products Are Unlikely To Make A Significant Impact On The...

Mon Nov 26, 2007 9:00pm EST

[-] Text [+]

Cardiovascular Pipeline Products Are Unlikely To Make A Significant Impact On The Market With Only 16% ($11.9 Billion) Of 2016 Sales Generated From The Current Pipeline

DUBLIN, Ireland--(Business Wire)--Research and Markets
(http://www.researchandmarkets.com/reports/c75499) has announced the
addition of "Commercial Insight: Cardiovascular Market Overview - Raft
of Patent Expires Threaten Blockbusters" to their offering.

Introduction

The cardiovascular market is expected to remain stable with sales
only showing negligible growth between 2006 and 2016, below the 3%
growth predicted for the SU sold. Generic products will become
increasingly important as the majority of products will have lost IP
protection, accounting for 30% of cardiovascular sales and 65% of SU
sold in 2016.

Scope

- Comprehensive analysis of the cardiovascular market by disease
area in each of the seven major markets

- An assessment of trends within the cardiovascular market between
2003 and 2006.

- Intellectual Property risk assessment for Top 10 brands in each
market.

- Forecast models for key brands, active agents and pipeline
products up to 2016.

Highlights

The cardiovascular market in the seven major markets is a mature
market with negligible sales growth between 2006 and 2016. Growth of
SU sold in the cardiovascular market is expected to increase by 3%,
driven by population growth, leaving an effective cardiovascular sales
growth of -3%. Use of generics will increase as key products lose
patent protection and healthcare providers push for greater cost
containment. Patent expiries during the pivotal 2010-13 window expose
$30.9 billion worth of branded drugs to generic competition.
Cardiovascular pipeline products are unlikely to make a significant
impact on the market with only 16% ($11.9 billion) of 2016 sales
generated from the current pipeline. A number of blockbuster products
are likely to be launched but the sales are likely to be greatly
reduced from the levels seen in 2006.

Reasons to Purchase

- Understand market specific drivers and predict the future
potential of key cardiovascular brands

- Quantify the impact of key patent expiries and product launches
and gain a valuable insight into the market dynamics

- Consider, assess and react to opportunities and risks
influencing the leading cardiovascular brands

Report Breakdown

Chapter 1 Executive Summary

Chapter 2 Market Overview And Dynamics

Chapter 3 Market Analysis

Chapter 4 Country Market Assessments

Chapter 5 Forecast Analysis

Appendix A - Bibliography

Appendix B - Market Forecast Data